Molecular imaging enables the
visualization of the cellular function by providing detailed pictures of
what is happening inside the body at the molecular and cellular level.
Unlike other diagnostic imaging procedures that offer anatomical
pictures, molecular imaging allows physicians to see how the body is
functioning and to measure its chemical and biological processes.
emission tomography (PET) is a specific type of molecular imaging
technique that provides physicians with information about the
performance of tissues and organs. PET is often used in combination with
computerized tomography (CT) imaging. It uses a scanner and a small
amount of radiopharmaceutical that is injected into a patient's vein to
assist in making detailed, computerized pictures of areas inside the
PET is often used to evaluate:
- Bone disorders
- Effectiveness of treatments
- Gastrointestinal disorders
- Heart conditions
- Kidney and thyroid disorders
- Lung disorders
- Neurological diseases such as Alzheimer's and multiple sclerosis
The PET Group has four subcommittees: Coverage, Coding and Payment, Advocacy and Education, Value and Evidence and Regulatory.
imaging drives effective patient care through screening, diagnosis, and
treatment. Members develop Standards and provide technical advice for
PET and SPECT (single-photon emission computerized tomography) scanners.
Through the PET Group, Members engage legislative and regulatory
decision-makers and build relationships with clinicians and patient